tadalafil and its Impurities

Tadalafil is used to treat male erectile dysfunction. It is marketed worldwide under the brand name Cialis. Tadalafil is an orally administered drug.Reference standards of Tadalafil API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 93 results for tadalafil Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 20 02000

Tadalafil

Tadalafil


  • Catalogue No.:PA 20 02000

  • CAS :

    171596-29-5

  • Molecular Formula : C22H19N3O4

  • Molecular Weight : 389.40

Drug Reference Standards & Impurity Synthesis in India
PA 20 02010

Tadalafil - Impurity A

(6R,12aS)-6-(1,3-Benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione


  • Catalogue No.:PA 20 02010

  • CAS :

    171596-27-3

  • Molecular Formula : C22H19N3O4

  • Molecular Weight : 389.40

Drug Reference Standards & Impurity Synthesis in India
PA 20 02020

Tadalafil - Impurity B

(6S,12aS)-6-(1,3-Benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione


  • Catalogue No.:PA 20 02020

  • CAS :

    629652-72-8

  • Molecular Formula : C22H19N3O4

  • Molecular Weight : 389.40

Drug Reference Standards & Impurity Synthesis in India
PA 20 02030

Tadalafil - Impurity C

(6S,12aR)-6-(1,3-Benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione


  • Catalogue No.:PA 20 02030

  • CAS :

    171596-28-4

  • Molecular Formula : C22H19N3O4

  • Molecular Weight : 389.40

Drug Reference Standards & Impurity Synthesis in India
PA 20 02040

Tadalafil - Impurity D

(6bR)-12-(1,3-Benzodioxol-5-yl)-12a-hydroxy-8-methyl-6a,6b,8,9,12,12a-hexahydropyrazino[1′,2′:1,2]pyrrolo[3,4-c]quinoline-6,7,10(5H)-trione


  • Catalogue No.:PA 20 02040

  • CAS :

    NA

  • Molecular Formula : C22H19N3O6

  • Molecular Weight : 421.40

Drug Reference Standards & Impurity Synthesis in India
PA 20 02050

Tadalafil - Impurity E

Aminohemiketal


  • Catalogue No.:PA 20 02050

  • CAS :

    2520114-41-2

  • Molecular Formula : C22H19N3O6

  • Molecular Weight : 421.40

Drug Reference Standards & Impurity Synthesis in India
PA 20 02060

Tadalafil - Impurity F

(8a′R)-6′-(1,3-Benzodioxol-5-yl)-2′-methyl-2′,3′,8′,8a′-tetrahydro-6′H-spiro[3,1-benzoxazine-4,7′-pyrrolo[1,2-a]pyrazine]-1′,2,4′(1H)-trione


  • Catalogue No.:PA 20 02060

  • CAS :

    2747958-44-5

  • Molecular Formula : C22H19N3O6

  • Molecular Weight : 421.40

Drug Reference Standards & Impurity Synthesis in India
PA 20 02070

Tadalafil - Impurity G

(12bR)-6-(1,3-Benzodioxol-5-yl)-12-hydroxy-2-methyl-2,3,6,12b-tetrahydropyrazino[1′,2′:1,5]pyrrolo[3,4-b]quinoline-1,4-dione


  • Catalogue No.:PA 20 02070

  • CAS :

    2520114-46-7

  • Molecular Formula : C22H17N3O5

  • Molecular Weight : 403.39

Drug Reference Standards & Impurity Synthesis in India
PA 20 02080

Tadalafil - Impurity H

Tadalafil Ketolactam


  • Catalogue No.:PA 20 02080

  • CAS :

    1978322-98-3

  • Molecular Formula : C22H19N3O6

  • Molecular Weight : 421.40

Drug Reference Standards & Impurity Synthesis in India
PA 20 02090

Tadalafil - Impurity I

Spiro-oxindole


  • Catalogue No.:PA 20 02090

  • CAS :

    2378614-29-8

  • Molecular Formula : C22H19N3O5

  • Molecular Weight : 405.40

Drug Reference Standards & Impurity Synthesis in India
PA 20 02520

2'-Oxo Tadalafil

2'-Oxo Tadalafil


  • Catalogue No.:PA 20 02520

  • CAS :

    1346602-17-2

  • Molecular Formula : C22H17N3O5

  • Molecular Weight : 403.39

Drug Reference Standards & Impurity Synthesis in India
PA 20 02530

Tadalafil Epoxide

Tadalafil Epoxide


  • Catalogue No.:PA 20 02530

  • CAS :

    NA

  • Molecular Formula : C22H19N3O5

  • Molecular Weight : 405.4

Drug Reference Standards & Impurity Synthesis in India
PA 20 02540

N-Butyl Nortadalafil

N-Butyl Nortadalafil


  • Catalogue No.:PA 20 02540

  • CAS :

    171596-31-9

  • Molecular Formula : C25H25N3O4

  • Molecular Weight : 431.48

Drug Reference Standards & Impurity Synthesis in India
PA 20 02550

(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate

(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate


  • Catalogue No.:PA 20 02550

  • CAS :

    171489-59-1

  • Molecular Formula : C22H19ClN2O5

  • Molecular Weight : 426.85

Drug Reference Standards & Impurity Synthesis in India
PA 20 02560

(1R,3S)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate

(1R,3S)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate


  • Catalogue No.:PA 20 02560

  • CAS :

    171596-44-4

  • Molecular Formula : C20H18N2O4

  • Molecular Weight : 350.37

Drug Reference Standards & Impurity Synthesis in India
PA 20 02570

(1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester

(1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester


  • Catalogue No.:PA 20 02570

  • CAS :

    171596-43-3

  • Molecular Formula : C20H18N2O4

  • Molecular Weight : 350.37

Drug Reference Standards & Impurity Synthesis in India
PA 20 02580

(1S,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate

(1S,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate


  • Catalogue No.:PA 20 02580

  • CAS :

    171596-42-2

  • Molecular Formula : C20H18N2O4

  • Molecular Weight : 350.37

Drug Reference Standards & Impurity Synthesis in India
PA 20 02590

(1S,3S)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester

(1S,3S)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester


  • Catalogue No.:PA 20 02590

  • CAS :

    629652-42-2

  • Molecular Formula : C22H19ClN2O5

  • Molecular Weight : 426.85

Drug Reference Standards & Impurity Synthesis in India
PA 20 02600

(1S,3R)-1-Benzo[1,3]dioxol-5-yl-2-(2-chloro-acetyl)-2,3,4,9-tetrahydro-1H-b-carboline-3-carboxylic Acid Methyl Ester

(1S,3R)-1-Benzo[1,3]dioxol-5-yl-2-(2-chloro-acetyl)-2,3,4,9-tetrahydro-1H-b-carboline-3-carboxylic Acid Methyl Ester


  • Catalogue No.:PA 20 02600

  • CAS :

    629652-40-0

  • Molecular Formula : C22H19ClN2O5

  • Molecular Weight : 426.85

Drug Reference Standards & Impurity Synthesis in India
PA 20 02610

(1R,3S)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester

(1R,3S)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester


  • Catalogue No.:PA 20 02610

  • CAS :

    629652-44-4

  • Molecular Formula : C22H19ClN2O5

  • Molecular Weight : 426.85

Drug Reference Standards & Impurity Synthesis in India
PA 20 02620

1,3-Benzodioxole

1,3-Benzodioxole


  • Catalogue No.:PA 20 02620

  • CAS :

    274-09-9

  • Molecular Formula : C7H6O2

  • Molecular Weight : 122.12

Drug Reference Standards & Impurity Synthesis in India
PA 20 02630

5-Methylbenzo[d][1,3]dioxole

5-Methylbenzo[d][1,3]dioxole


  • Catalogue No.:PA 20 02630

  • CAS :

    7145-99-5

  • Molecular Formula : C8H8O2

  • Molecular Weight : 136.15

Drug Reference Standards & Impurity Synthesis in India
PA 20 02640

Tadalafil and Lactose Mixture

Tadalafil and Lactose Mixture


  • Catalogue No.:PA 20 02640

  • CAS :

    NA

  • Molecular Formula : C34H41N3O15

  • Molecular Weight : 731.7

Drug Reference Standards & Impurity Synthesis in India
PA 20 02650

5-(1,3-Benzodioxol-5-yl)-1-piperidin-1-ylpentan-1-one

5-(1,3-Benzodioxol-5-yl)-1-piperidin-1-ylpentan-1-one


  • Catalogue No.:PA 20 02650

  • CAS :

    23434-88-0

  • Molecular Formula : C17H23NO3

  • Molecular Weight : 289.36

Drug Reference Standards & Impurity Synthesis in India
PA 20 02660

(6R)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-((3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione

(6R)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-((3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione


  • Catalogue No.:PA 20 02660

  • CAS :

    NA

  • Molecular Formula : C28H29N3O9

  • Molecular Weight : 551.54

Drug Reference Standards & Impurity Synthesis in India
PA 20 02670

(6R)-6-(Benzo[d][1,3]dioxol-5-yl)-7-((3R,4S,6R)-3,4-bis(2-hydroxypropoxy)-6-((2-hydroxypropoxy)methyl)-5-(((3R,4S,5S,6R)-3,4,5-tris(2-hydroxypropoxy)-6-((2-hydroxypropoxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione

(6R)-6-(Benzo[d][1,3]dioxol-5-yl)-7-((3R,4S,6R)-3,4-bis(2-hydroxypropoxy)-6-((2-hydroxypropoxy)methyl)-5-(((3R,4S,5S,6R)-3,4,5-tris(2-hydroxypropoxy)-6-((2-hydroxypropoxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione


  • Catalogue No.:PA 20 02670

  • CAS :

    NA

  • Molecular Formula : C55H81N3O21

  • Molecular Weight : 1120.24

Drug Reference Standards & Impurity Synthesis in India
PA 20 02680

(6R)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-((3R,4S,5S,6R)-3,4,5-tris(2-hydroxypropoxy)-6-((2-hydroxypropoxy)methyl)tetrahydro-2H-pyran-2-yl)-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione

(6R)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-((3R,4S,5S,6R)-3,4,5-tris(2-hydroxypropoxy)-6-((2-hydroxypropoxy)methyl)tetrahydro-2H-pyran-2-yl)-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione


  • Catalogue No.:PA 20 02680

  • CAS :

    NA

  • Molecular Formula : C40H53N3O13

  • Molecular Weight : 783.86

Drug Reference Standards & Impurity Synthesis in India
PA 20 02690

(6R)-6-(benzo[d][1,3]dioxol-5-yl)-2,7-dimethyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione

(6R)-6-(benzo[d][1,3]dioxol-5-yl)-2,7-dimethyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione


  • Catalogue No.:PA 20 02690

  • CAS :

    NA

  • Molecular Formula : C23H21N3O4

  • Molecular Weight : 403.43

Drug Reference Standards & Impurity Synthesis in India
PA 20 02700

(6R)-6-(Benzo[d][1,3]dioxol-5-yl)-7-(hydroxymethyl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione

(6R)-6-(Benzo[d][1,3]dioxol-5-yl)-7-(hydroxymethyl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione


  • Catalogue No.:PA 20 02700

  • CAS :

    NA

  • Molecular Formula : C23H21N3O5

  • Molecular Weight : 419.43

Drug Reference Standards & Impurity Synthesis in India
PA 20 02710

(6R)-6-(Benzo[d][1,3]dioxol-5-yl)-7-(hydroxy(5-(hydroxymethyl)furan-2-yl)methyl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione

(6R)-6-(Benzo[d][1,3]dioxol-5-yl)-7-(hydroxy(5-(hydroxymethyl)furan-2-yl)methyl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione


  • Catalogue No.:PA 20 02710

  • CAS :

    NA

  • Molecular Formula : C28H25N3O7

  • Molecular Weight : 515.51

Drug Reference Standards & Impurity Synthesis in India
PA STI 016650

N-Butyl Nortadalafil-d9

N-Butyl Nortadalafil-d9


  • Catalogue No.:PA STI 016650

  • CAS :

    NA

  • Molecular Formula : C25H16D9N3O4

  • Molecular Weight : 440.54

Drug Reference Standards & Impurity Synthesis in India
PA STI 051350

2-Hydroxypropyl-d6 Nortadalafil

2-Hydroxypropyl-d6 Nortadalafil


  • Catalogue No.:PA STI 051350

  • CAS :

    NA

  • Molecular Formula : C24H17D6N3O5

  • Molecular Weight : 439.49

Drug Reference Standards & Impurity Synthesis in India
PA STI 069740

N-Octyl Nortadalafil-d17

N-Octyl Nortadalafil-d17


  • Catalogue No.:PA STI 069740

  • CAS :

    NA

  • Molecular Formula : C29H16D17N3O4

  • Molecular Weight : 504.69

Drug Reference Standards & Impurity Synthesis in India
PA STI 080740

ent-Tadalafil-d3

ent-Tadalafil-d3


  • Catalogue No.:PA STI 080740

  • CAS :

    1329568-92-4

  • Molecular Formula : C22H16D3N3O4

  • Molecular Weight : 392.42

Drug Reference Standards & Impurity Synthesis in India
PA STI 080750

Tadalafil-d3

Tadalafil-d3


  • Catalogue No.:PA STI 080750

  • CAS :

    960226-55-5

  • Molecular Formula : C22H16D3N3O4

  • Molecular Weight : 392.42

Drug Reference Standards & Impurity Synthesis in India
PA STI 080760

cis-Tadalafil-d3

cis-Tadalafil-d3


  • Catalogue No.:PA STI 080760

  • CAS :

    NA

  • Molecular Formula : C22H16D3N3O4

  • Molecular Weight : 392.42

Drug Reference Standards & Impurity Synthesis in India
PA STI 080770

cis-ent-Tadalafil-d3

cis-ent-Tadalafil-d3


  • Catalogue No.:PA STI 080770

  • CAS :

    1329799-70-3

  • Molecular Formula : C22H16D3N3O4

  • Molecular Weight : 392.42

Drug Reference Standards & Impurity Synthesis in India
PA 20 02730

Tadalafil N-Desmethyl N-Amino

Tadalafil N-Desmethyl N-Amino


  • Catalogue No.:PA 20 02730

  • CAS :

    385769-84-6

  • Molecular Formula : C21H18N4O4

  • Molecular Weight : 390.4

Drug Reference Standards & Impurity Synthesis in India
PA 20 02740

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2,9-bis(2-chloroacetyl)-N-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2,9-bis(2-chloroacetyl)-N-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide


  • Catalogue No.:PA 20 02740

  • CAS :

    NA

  • Molecular Formula : C24H21Cl2N3O5

  • Molecular Weight : 502.35

Drug Reference Standards & Impurity Synthesis in India
PA 20 02750

(6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-7-(2-chloroacetyl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione

(6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-7-(2-chloroacetyl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione


  • Catalogue No.:PA 20 02750

  • CAS :

    2520114-95-6

  • Molecular Formula : C24H20ClN3O5

  • Molecular Weight : 465.89

Drug Reference Standards & Impurity Synthesis in India
PA EPY0001417

Tadalafil (Y0001417)

Tadalafil (Y0001417)


  • Catalogue No.:PA EPY0001417

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA USP1642879

Tadalafil (1642879)

Tadalafil (1642879)


  • Catalogue No.:PA USP1642879

  • CAS :

    171596-29-5

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA 20 02760

(1R,3R)-Methyl-1,2,3,4-tetrahydro-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate

(1R,3R)-Methyl-1,2,3,4-tetrahydro-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate


  • Catalogue No.:PA 20 02760

  • CAS :

    171596-41-1

  • Molecular Formula : C20H18N2O4

  • Molecular Weight : 350.37

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021000

(3R)-3-[[2-(1,3-Benzodioxol-5-ylcarbonyl)-1H-indol-3-yl]methyl]-1-methyl-2,5-piperazinedione

(3R)-3-[[2-(1,3-Benzodioxol-5-ylcarbonyl)-1H-indol-3-yl]methyl]-1-methyl-2,5-piperazinedione


  • Catalogue No.:PA 20 0021000

  • CAS :

    1220393-12-3

  • Molecular Formula : C22H19N3O5

  • Molecular Weight : 405.41

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021001

N-(1-(Benzo[d][1,3]dioxol-5-yl)-9H-pyrido[3,4-b]indole-3-carbonyl)-N-methylglycine

N-(1-(Benzo[d][1,3]dioxol-5-yl)-9H-pyrido[3,4-b]indole-3-carbonyl)-N-methylglycine


  • Catalogue No.:PA 20 0021001

  • CAS :

    NA

  • Molecular Formula : C22H17N3O5

  • Molecular Weight : 403.39

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021002

(1R,3R)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]indole-3-carboxamide

(1R,3R)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]indole-3-carboxamide


  • Catalogue No.:PA 20 0021002

  • CAS :

    951661-81-7

  • Molecular Formula : C22H20ClN3O4

  • Molecular Weight : 425.87

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021003

Desmethylene Tadalafil

Desmethylene Tadalafil


  • Catalogue No.:PA 20 0021003

  • CAS :

    171489-03-5

  • Molecular Formula : C21H19N3O4

  • Molecular Weight : 377.4

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021004

N-Octyl Nortadalafil

N-Octyl Nortadalafil


  • Catalogue No.:PA 20 0021004

  • CAS :

    1173706-35-8

  • Molecular Formula : C29H33N3O4

  • Molecular Weight : 487.6

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021005

 (2R)-Methyl 2-amino-3-(3H-indol-3-yl)propanoate hydrochloride

(2R)-Methyl 2-amino-3-(3H-indol-3-yl)propanoate hydrochloride


  • Catalogue No.:PA 20 0021005

  • CAS :

    14907-27-8

  • Molecular Formula : C12H15ClN2O2

  • Molecular Weight : 254.71

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021006

(6S,12aS)-6-(3,4-Dihydroxyphenyl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione

(6S,12aS)-6-(3,4-Dihydroxyphenyl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione


  • Catalogue No.:PA 20 0021006

  • CAS :

    2520114-84-3

  • Molecular Formula : C21H19N3O4

  • Molecular Weight : 377.4

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021007

(6R,12aS)-6-(3,4-Dihydroxyphenyl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione

(6R,12aS)-6-(3,4-Dihydroxyphenyl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione


  • Catalogue No.:PA 20 0021007

  • CAS :

    NA

  • Molecular Formula : C21H19N3O4

  • Molecular Weight : 377.4

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021008

Nortadalafil

Nortadalafil


  • Catalogue No.:PA 20 0021008

  • CAS :

    171596-36-4

  • Molecular Formula : C21H17N3O4

  • Molecular Weight : 375.38

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021009

Methyl (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(dimethylglycyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate

Methyl (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(dimethylglycyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate


  • Catalogue No.:PA 20 0021009

  • CAS :

    2169996-11-4

  • Molecular Formula : C24H25N3O5

  • Molecular Weight : 435.48

Drug Reference Standards & Impurity Synthesis in India
PA IPRS 113 15

Tadalafil (IPRS/113/15) - from IPC

Tadalafil (IPRS/113/15) - from IPC


  • Catalogue No.:PA IPRS 113 15

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021010

(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride

(1R,3R)-Methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride


  • Catalogue No.:PA 20 0021010

  • CAS :

    171752-68-4

  • Molecular Formula : C20H19ClN2O4

  • Molecular Weight : 386.83

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021011

(2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-(2-methoxy-4-((6R,12aR)-2-methyl-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino[1',2':1,6]pyrido[3,4-b]indol-6-yl)phenoxy)tetrahydro-2H-pyran-2-carboxylic Acid

(2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-(2-methoxy-4-((6R,12aR)-2-methyl-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino[1',2':1,6]pyrido[3,4-b]indol-6-yl)phenoxy)tetrahydro-2H-pyran-2-carboxylic Acid


  • Catalogue No.:PA 20 0021011

  • CAS :

    378788-18-2

  • Molecular Formula : C28H29N3O10

  • Molecular Weight : 567.55

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021012

(6R,12aR)-6-(4-Hydroxy-3-methoxyphenyl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione

(6R,12aR)-6-(4-Hydroxy-3-methoxyphenyl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione


  • Catalogue No.:PA 20 0021012

  • CAS :

    378788-16-0

  • Molecular Formula : C22H21N3O4

  • Molecular Weight : 391.43

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021013

1,3-Benzodioxole-5-glycolic Acid

1,3-Benzodioxole-5-glycolic Acid


  • Catalogue No.:PA 20 0021013

  • CAS :

    27738-46-1

  • Molecular Formula : C9H8O5

  • Molecular Weight : 196.16

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021014

N-Nitroso Tadalafil

N-Nitroso Tadalafil


  • Catalogue No.:PA 20 0021014

  • CAS :

    NA

  • Molecular Formula : C22H18N4O5

  • Molecular Weight : 418.41

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021015

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide


  • Catalogue No.:PA 20 0021015

  • CAS :

    1370438-57-5

  • Molecular Formula : C19H17N3O3

  • Molecular Weight : 335.36

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021016

N-Desmethyl ent-Tadalafil

N-Desmethyl ent-Tadalafil


  • Catalogue No.:PA 20 0021016

  • CAS :

    929100-66-3

  • Molecular Formula : C21H17N3O4

  • Molecular Weight : 375.38

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021017

Methyl (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-9-nitroso-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate

Methyl (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-9-nitroso-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate


  • Catalogue No.:PA 20 0021017

  • CAS :

    NA

  • Molecular Formula : C20H17N3O5

  • Molecular Weight : 379.37

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021018

Methyl (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-nitroso-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate

Methyl (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-nitroso-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate


  • Catalogue No.:PA 20 0021018

  • CAS :

    NA

  • Molecular Formula : C20H17N3O5

  • Molecular Weight : 379.37

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021019

Methyl (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2,9-dinitroso-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate

Methyl (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2,9-dinitroso-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate


  • Catalogue No.:PA 20 0021019

  • CAS :

    NA

  • Molecular Formula : C20H16N4O6

  • Molecular Weight : 408.37

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021020

Methyl (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(2-chloroacetyl)-9-nitroso-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate

Methyl (1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2-(2-chloroacetyl)-9-nitroso-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate


  • Catalogue No.:PA 20 0021020

  • CAS :

    NA

  • Molecular Formula : C22H18ClN3O6

  • Molecular Weight : 455.85

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021021

(6bR,12R)-12-(Benzo[d][1,3]dioxol-5-yl)-12a-hydroxy-8-methyl-6a,6b,8,9,12,12a-hexahydropyrazino[1',2':1,2]pyrrolo[3,4-c]quinoline-6,7,10(5H)-trione

(6bR,12R)-12-(Benzo[d][1,3]dioxol-5-yl)-12a-hydroxy-8-methyl-6a,6b,8,9,12,12a-hexahydropyrazino[1',2':1,2]pyrrolo[3,4-c]quinoline-6,7,10(5H)-trione


  • Catalogue No.:PA 20 0021021

  • CAS :

    2194574-01-9

  • Molecular Formula : C22H19N3O6

  • Molecular Weight : 421.41

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021022

(6R,12bR)-6-(Benzo[d][1,3]dioxol-5-yl)-12-hydroxy-2-methyl-2,3,6,12b-tetrahydropyrazino[1',2':1,5]pyrrolo[3,4-b]quinoline-1,4-dione

(6R,12bR)-6-(Benzo[d][1,3]dioxol-5-yl)-12-hydroxy-2-methyl-2,3,6,12b-tetrahydropyrazino[1',2':1,5]pyrrolo[3,4-b]quinoline-1,4-dione


  • Catalogue No.:PA 20 0021022

  • CAS :

    1978323-00-0

  • Molecular Formula : C22H17N3O5

  • Molecular Weight : 403.39

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021023

Tadalafil Hydroxypiperidone

Tadalafil Hydroxypiperidone


  • Catalogue No.:PA 20 0021023

  • CAS :

    1978322-99-4

  • Molecular Formula : C22H19N3O6

  • Molecular Weight : 421.41

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021024

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Hydrochloride

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Hydrochloride


  • Catalogue No.:PA 20 0021024

  • CAS :

    474668-76-3

  • Molecular Formula : C19H17ClN2O4

  • Molecular Weight : 372.81

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021025

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid


  • Catalogue No.:PA 20 0021025

  • CAS :

    2058231-08-4

  • Molecular Formula : C21H17ClN2O5

  • Molecular Weight : 412.83

Drug Reference Standards & Impurity Synthesis in India
PA STI 089475

Tadalafil 13CD3

Tadalafil 13CD3


  • Catalogue No.:PA STI 089475

  • CAS :

    1261364-86-6

  • Molecular Formula : C2113CH16D3N3O4

  • Molecular Weight : 393.42

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021026

N-Desmethyl-N-cyclopentyl Tadalafil

N-Desmethyl-N-cyclopentyl Tadalafil


  • Catalogue No.:PA 20 0021026

  • CAS :

    171596-32-0

  • Molecular Formula : C26H25N3O4

  • Molecular Weight : 443.5

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021027

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-N-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-N-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide


  • Catalogue No.:PA 20 0021027

  • CAS :

    951661-82-8

  • Molecular Formula : C20H19N3O3

  • Molecular Weight : 349.39

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021028

(1S,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(2-chloroacetyl)-N-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide

(1S,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(2-chloroacetyl)-N-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide


  • Catalogue No.:PA 20 0021028

  • CAS :

    951661-84-0

  • Molecular Formula : C22H20ClN3O4

  • Molecular Weight : 425.87

Drug Reference Standards & Impurity Synthesis in India
PA IPRST029

Tadalafil (IPRST029)

Tadalafil (IPRST029)


  • Catalogue No.:PA IPRST029

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021029

Methyl 1-(benzo[d][1,3]dioxol-5-yl)-9H-pyrido[3,4-b]indole-3-carboxylate

Methyl 1-(benzo[d][1,3]dioxol-5-yl)-9H-pyrido[3,4-b]indole-3-carboxylate


  • Catalogue No.:PA 20 0021029

  • CAS :

    321862-32-2

  • Molecular Formula : C20H14N2O4

  • Molecular Weight : 346.34

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021031

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2-nitroso-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2-nitroso-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid


  • Catalogue No.:PA 20 0021031

  • CAS :

    NA

  • Molecular Formula : C19H15N3O5

  • Molecular Weight : 365.35

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021032

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid


  • Catalogue No.:PA 20 0021032

  • CAS :

    406938-39-4

  • Molecular Formula : C19H16N2O4

  • Molecular Weight : 336.35

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021033

Methoxyoxomethyl Tadalafil Dichloride

Methoxyoxomethyl Tadalafil Dichloride


  • Catalogue No.:PA 20 0021033

  • CAS :

    1598416-08-0

  • Molecular Formula : C22H18Cl2N2O5

  • Molecular Weight : 461.3

Drug Reference Standards & Impurity Synthesis in India
PA BSC 00220996

Tadalafil (BSC)

Tadalafil (BSC)


  • Catalogue No.:PA BSC 00220996

  • CAS :

    171596-29-5

  • Molecular Formula : C22H19N3O4

  • Molecular Weight : 389.41

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021034

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(methylglycyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(methylglycyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid


  • Catalogue No.:PA 20 0021034

  • CAS :

    2058231-15-3

  • Molecular Formula : C22H21N3O5

  • Molecular Weight : 407.43

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021035

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(N-methyl-N-nitrosoglycyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid

(1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(N-methyl-N-nitrosoglycyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid


  • Catalogue No.:PA 20 0021035

  • CAS :

    NA

  • Molecular Formula : C22H20N4O6

  • Molecular Weight : 436.42

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021036

N-Methyl-N-(methylglycyl)glycine

N-Methyl-N-(methylglycyl)glycine


  • Catalogue No.:PA 20 0021036

  • CAS :

    38082-70-1

  • Molecular Formula : C6H12N2O3

  • Molecular Weight : 160.17

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021037

N-((1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carbonyl)-N-methylglycine

N-((1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carbonyl)-N-methylglycine


  • Catalogue No.:PA 20 0021037

  • CAS :

    NA

  • Molecular Formula : C22H21N3O5

  • Molecular Weight : 407.43

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021038

N,N'-Carbonylbis(N-cyclohexyl-2-(methylamino)acetamide)

N,N'-Carbonylbis(N-cyclohexyl-2-(methylamino)acetamide)


  • Catalogue No.:PA 20 0021038

  • CAS :

    NA

  • Molecular Formula : C19H34N4O3

  • Molecular Weight : 366.51

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021039

3-Cyclohexyl-2-(cyclohexylimino)-1-methylimidazolidin-4-one

3-Cyclohexyl-2-(cyclohexylimino)-1-methylimidazolidin-4-one


  • Catalogue No.:PA 20 0021039

  • CAS :

    2998946-29-3

  • Molecular Formula : C16H27N3O

  • Molecular Weight : 277.41

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021040

N-Cyclohexyl-N-(cyclohexylcarbamoyl)-2-(methylamino)acetamide

N-Cyclohexyl-N-(cyclohexylcarbamoyl)-2-(methylamino)acetamide


  • Catalogue No.:PA 20 0021040

  • CAS :

    2998946-28-2

  • Molecular Formula : C16H29N3O2

  • Molecular Weight : 295.43

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021041

Ethyl N-methyl-N-(methylglycyl)glycinate

Ethyl N-methyl-N-(methylglycyl)glycinate


  • Catalogue No.:PA 20 0021041

  • CAS :

    1857709-99-9

  • Molecular Formula : C8H16N2O3

  • Molecular Weight : 188.23

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021042

N-(N-((1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carbonyl)-N-methylglycyl)-N-methylglycine

N-(N-((1R,3R)-1-(Benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carbonyl)-N-methylglycyl)-N-methylglycine


  • Catalogue No.:PA 20 0021042

  • CAS :

    NA

  • Molecular Formula : C25H26N4O6

  • Molecular Weight : 478.51

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021043

1,4-Dimethylpiperazine-2,5-dione

1,4-Dimethylpiperazine-2,5-dione


  • Catalogue No.:PA 20 0021043

  • CAS :

    5076-82-4

  • Molecular Formula : C6H10N2O2

  • Molecular Weight : 142.16

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021044

(6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-7-hydroxy-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione

(6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-7-hydroxy-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione


  • Catalogue No.:PA 20 0021044

  • CAS :

    NA

  • Molecular Formula : C22H19N3O5

  • Molecular Weight : 405.41

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021045

(R)-N-(1-(Benzo[d][1,3]dioxol-5-yl)-9-hydroxy-3,9-dihydro-2H-pyrido[3,4-b]indole-3-carbonyl)-N-methylglycine

(R)-N-(1-(Benzo[d][1,3]dioxol-5-yl)-9-hydroxy-3,9-dihydro-2H-pyrido[3,4-b]indole-3-carbonyl)-N-methylglycine


  • Catalogue No.:PA 20 0021045

  • CAS :

    NA

  • Molecular Formula : C22H19N3O6

  • Molecular Weight : 421.41

Drug Reference Standards & Impurity Synthesis in India
PA 20 0021046

(R)-6-(Benzo[d][1,3]dioxol-5-yl)-7-hydroxy-2-methyl-2,3,7,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione

(R)-6-(Benzo[d][1,3]dioxol-5-yl)-7-hydroxy-2-methyl-2,3,7,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione


  • Catalogue No.:PA 20 0021046

  • CAS :

    NA

  • Molecular Formula : C22H17N3O5

  • Molecular Weight : 403.39

pharmaffiliates